BIOARTIFICIAL GEL TECHNOLOGIES INC has a total of 27 patent applications. Its first patent ever was published in 1994. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and Canada. Its main competitors in its focus markets macromolecular chemistry and polymers, pharmaceuticals and medical technology are PHARMACEUTICAL DELIVERY SYSTEM, PHARMARESEARCH PRODUCTS CO LTD and MEDIVAS LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 8 | |
#2 | EPO (European Patent Office) | 7 | |
#3 | Canada | 6 | |
#4 | Australia | 2 | |
#5 | Hong Kong | 2 | |
#6 | United States | 2 |
# | Industry | |
---|---|---|
#1 | Macromolecular chemistry and polymers | |
#2 | Pharmaceuticals | |
#3 | Medical technology | |
#4 | Machines | |
#5 | Organic fine chemistry | |
#6 | Optics |
# | Name | Total Patents |
---|---|---|
#1 | Faure Marie-Pierre | 26 |
#2 | Shingel Kirill | 8 |
#3 | Brisson Jean-Francois | 8 |
#4 | Martinu Ludvik | 4 |
#5 | Pinard Karl | 4 |
#6 | Klemberg-Sapieha Jolanta | 4 |
#7 | Zabeida Oleg | 4 |
#8 | Ibea Michel | 3 |
#9 | Robert Marielle | 3 |
#10 | Ibea Micheal | 1 |
Publication | Filing date | Title |
---|---|---|
CA2631497A1 | Emulsions of a protein-crosslinked hydrogel matrix and dispersed hydrophobic phase | |
WO2006105665A1 | Hydrogel composition for modulation of topical inflammatory response | |
CA2602612A1 | Prevention and treatment of radiation dermatitis | |
US2005228187A1 | Process for the preparation of activated polyethylene glycols | |
EP1680148A1 | Hydrogel-containing medical articles and methods of using and making the same | |
EP1419191A1 | Process for the preparation of activated polyethylene glycols | |
AU2002245961A1 | Hydrogel attached to backing and method for making same | |
EP1280849A1 | Process for the preparation of proteinbased hydrogels |